TickerFactsScreenerDevelopers

IMMUNIC, INC. (IMUX) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2016: -$35.77M2017: -$40.40M2018: -$9.74M2019: -$28.55M2020: -$46.12M2021: -$83.23M2022: -$65.14M2023: -$70.83M2024: -$84.77M2025: -$85.81M-$85.81M
2016Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$85.81M-1.2%
2024-$84.77M-19.7%
2023-$70.83M-8.7%
2022-$65.14M+21.7%
2021-$83.23M-80.5%
2020-$46.12M-61.6%
2019-$28.55M-193.1%
2018-$9.74M+75.9%
2017-$40.40M-12.9%
2016-$35.77M—